(Press-News.org) Philadelphia, PA, July 15, 2015 - Peripartum cardiomyopathy (PPCM) is a rare disorder characterized by weakened pumping of the heart, or "left ventricular dysfunction," which results in otherwise healthy pregnant women experiencing heart failure shortly before or up to five months after they deliver healthy babies. Despite the seriousness of this condition, a new study published in the Canadian Journal of Cardiology revealed that no significant research has been undertaken to explore how to prevent or treat this disorder. In fact, only three studies of possible treatments have ever been conducted, and only two of those have shown any promise.
"Despite the serious illness and high risk of dying attributed to PPCM in young, otherwise healthy women, the evidence guiding clinicians in the treatment of this dramatic disease is scarce and of poor quality," explained lead investigator E. Marc Jolicoeur, MD, MSc, MHS, Associate Clinical Professor and Director of Research, Adult Interventional Cardiology Program, and first author Olivier Desplantie, MDCM, both of the Montreal Heart Institute, University of Montreal.
PPCM affects from 1 to 5 women per 10,000 live births. Despite current advances in heart failure treatment, mortality related to PPCM at one and ten years can be as high as 4% and 7%, respectively. These young, healthy women typically die from sudden cardiac death or progressive heart failure with 18% of deaths occurring by the first week and 87% by the sixth month after diagnosis. One in ten of these patients will require heart transplantation.
Following a comprehensive search of the medical literature, investigators identified two randomized controlled trials (RCT) that investigated the effects of the hormone bromocriptine and the drug levosimendan on PPCM, as well as a third, non-randomized prospective study of another drug, pentoxifylline. In the bromocriptine study, 80% of the patients receiving the drug experienced a significant reduction in adverse outcomes compared to10% of the control patients. However, this study included only 20 South African patients.
In the RCT of levosimendan, there were 24 patients enrolled. There was no difference in all-cause mortality and no differences in any other cardiac functional measurements between the therapy and control groups. In the third study reviewed, after providing standard care to 29 patients with PPCM, pentoxifylline was administered to 30 subsequent patients. Failure to improve was found in 52% of the standard care group, while only 27% of the pentoxifylline failed to improve.
For a disorder with such severe consequences, what can explain the apparent lack of interest? In an editorial in the same issue, Ricardo Cardona-Guarache, MD, MPH, and Jordana Kron, MD, of Virginia Commonwealth University, Richmond, Virginia, suggest several reasons.
First, because the pathophysiology of PPCM is not well understood, it is difficult to select potential therapies for trials. While more common treatments for heart failure, such as beta-blockers and ACE inhibitors, might be expected to help, results for women with PPCM have not been favorable.
Further Cardona-Guarache and Kron noted that, "Historically, exclusion of women from clinical trials was common practice, and the lack of data on pregnant women and women of childbearing age can make informed decision-making difficult for physicians and patients. Because PPCM occurs exclusively in women of childbearing age, it is an extreme example that highlights the systematic problem of gender bias in cardiovascular research." They added that women account for only 29% of patients in heart-failure trials and 25% in coronary artery disease trails.
"PPCM needs further high quality investigation to guide disease-specific therapy recommendations. We feel that the review by Jolicoeur and his co-investigators should serve as a call to action for investigators to renew efforts to further define the benefits of existing therapies and develop novel therapies for PPCM," stated Cardona-Guarache and Kron.
INFORMATION:
This news release is available in French. Fuel cells are regarded as the technology of the future for both cars and household heating systems. As a result, they have a key role to play in the switch to renewable energies. But are fuel cells always more environmentally friendly? An international team of scientists headed by Empa performed a series of calculations and reached a conclusion: it depends on the fuel.
In the future, we might be driving fuel-cell cars that burn solar-generated hydrogen. This would make the "zero emissions car" a reality. At the same time, ...
July 15, 2015 - Overdoses of opioid pain medications frequently occur in people who aren't chronic users with high prescribed opioid doses--the groups targeted by current opioid prescribing guidelines, reports a study in the August issue of Medical Care. The journal is published by Wolters Kluwer.
"It may be prudent to revise guidelines to also address opioid poisonings occurring at relatively low prescribed doses and with acute and intermittent opioid use, in addition to chronic, high-dose use," comments lead author Deborah Fulton-Kehoe, PhD, a research scientist in ...
CHICAGO --- You can fake a smile, but your phone knows the truth. Depression can be detected from your smartphone sensor data by tracking the number of minutes you use the phone and your daily geographical locations, reports a small Northwestern Medicine study.
The more time you spend using your phone, the more likely you are depressed. The average daily usage for depressed individuals was about 68 minutes, while for non-depressed individuals it was about 17 minutes.
Spending most of your time at home and most of your time in fewer locations -- as measured by GPS ...
Substantial improvements in the care and survival of older people with hip fracture in England have followed the introduction of a collaborative national initiative to tackle the issue, according to a new study published in the Medical Care journal.
Hip fracture is the most common serious injury of older people. In the UK there are around 70,000 cases per year (in people aged 60 years and older), while in the US there are approximately 250,000 cases (in people aged 65 years and older).
The UK National Hip Fracture Database (NHFD) is a clinician-led audit initiative ...
Epidural electrostimulation is a medical technique that has been used for several years now to help patients affected by paralysis due to a spinal cord injury. It involves implanting electrodes over the dorsal nerve roots (which convey incoming "sensory" inputs) of the spinal cord below the level of the trauma and applying electrical stimuli of varying intensity and frequency. This technique, which produces or helps produce activation patterns of the motor nerves (ventral, outgoing) has shown promising results, and the scientists hope that one day it will be able to help ...
Oxford, July 15, 2015 - A recent study, published in the International Journal of Nursing Studies, reveals a set of ten low-cost interventions that can increase safety on psychiatric wards. This Safewards Model reduces aggression, self-harm and other risky behaviours by 15% and reduces coercive control, such as restraint, by 24%.
The study stems from a 20-year research program led by Professor of Psychiatric Nursing, Len Bowers, at the Institute of Psychiatry, Psychology & Neuroscience, King's College London.
The study reveals that, by using a set of ten small, low ...
UK investment in pneumonia research is lacking when compared to spending on influenza and tuberculosis, according to a new study by the University of Southampton and University College London (UCL).
By calculating the amount spent on researching respiratory infections and their mortality rates, the study authors were able to assess UK public and charitable sector investment against the global burden of the diseases.
Published in EBioMedicine the study found that while £484.21 per death was invested in influenza research, less than a tenth of that figure (£43.08) ...
Findings, published today [15 Jul] in Nature Communications, reveal the extent a mutation associated with autism and epilepsy plays in impairing a biochemical process in the brain. The study, led by University of Bristol researchers, could provide a new target for treating neurological disorders.
The brain contains billions of nerve cells which communicate via the release of chemicals at connections called synapses. Each nerve cell can have thousands of synaptic connections to hundreds of other nerve cells. The protein Synapsin 1a plays a key role in regulating how synapses ...
Spinal cord injuries cause serious functional deficits, including paraplegia or tetraplegia, depending on the scale of the injury. This is due to degeneration of the spinal pathways that carry nerve signals from the brain to the various parts of the body, and vice versa, leading to loss of mobility and sensitivity below the injury.
An international team of scientists coordinated by Rubèn López Vales, of the Department of Cell Biology, Physiology and Immunology of the Universitat Autònoma de Barcelona (UAB), the UAB Institute of Neuroscience, and the Centre ...
Academies in some of the most socio-economically deprived areas of England are proving to be successful in raising academic achievement and aspirations among pupils, according to a new report.
Improved pupil behaviour and a greater level of engagement in learning, sharper focus on continued professional development for staff, and a more entrepreneurial style of leadership, often from a new head appointed at the time of transition, were all found to be characteristics of those studied in the research.
Led by education experts at Plymouth University and the Cornwall College ...
